Journal ArticleOPEN ACCESS

Study of CystatinC as Early Biomarker of Nephropathy in Patients with Type 2 DM and Risk Stratification in TarnakaHospital of Hyderabad City in India

  • H. A.ALsailawi
  • Mustafa Mudhafar
  • AlhusseinArkanMajhool
  • et al.
Journal of US-China Medical Science (2019) 16(5)
DOI: 10.17265/1548-6648/2019.05.004
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

… On the other hand, eGFR < 60 mL/min/1.73 m2 estimated by CKD-EPI equation was … for women. The eGFRcys level was calculated by the chronic kidney disease epidemiology (CKD-…

Cite

CITATION STYLE

APA

H. A.ALsailawi, Mustafa Mudhafar, AlhusseinArkanMajhool, & Abbas Asaad. (2019). Study of CystatinC as Early Biomarker of Nephropathy in Patients with Type 2 DM and Risk Stratification in TarnakaHospital of Hyderabad City in India. Journal of US-China Medical Science, 16(5). https://doi.org/10.17265/1548-6648/2019.05.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free